Chemours Co is 1.5x more valuable than INNOSPEC INC. by market capitalization ($3.02 B vs $2.05 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CC | IOSP |
|---|---|---|
| Market cap | $3.02 B | $2.05 B |
| US-listed rank | #1793 | #2083 |
| Revenue (latest FY) | $5.81B | $1.78B |
| Net income (latest FY) | -$386.00M | $119.50M |
| Net margin | -6.6% | 6.7% |
| P/E (trailing FY) | - | 17.1 |
| SEC filings | 979 | 1,749 |
Chemours Co is 1.5x more valuable than INNOSPEC INC. by market capitalization ($3.02 B vs $2.05 B).
In their latest fiscal years, Chemours Co reported $5.81B in revenue while INNOSPEC INC. reported $1.78B.
Full pages: Chemours Co and INNOSPEC INC., or browse the full rankings.